Prostate Cancer Daily

May 27, 2026

Videos

Peer-to-Peer Clinical Conversations

Rectal Spacers in Prostate Radiotherapy: Balancing Efficacy, Safety, and Patient Experience - Michael Greenberg & Daniel Welchons

Zachary Klaassen speaks with Michael Greenberg and Daniel Welchons about rectal spacing before prostate cancer radiotherapy.

PTEN Loss and the Future of Precision Treatment in mHSPC - Karim Fizazi & Noel Clarke

Karim Fizazi

Karim Fizazi and Noel Clarke discuss CAPItello-281 results with Neeraj Agrawal.

Beyond the Abstracts

Natural History of Untreated Prostate Cancer: A Comprehensive Review of Long-Term Progression Patterns and Survival Outcomes - Beyond the Abstract

Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis - Beyond the Abstract

Conference Coverage

AUA 2026: Extraperitoneal Robot-Assisted Radical Prostatectomy with the Hugo™ RAS System: 100 Consecutive Cases, 1-Year Follow-up and Surgical Learning Curve Evaluation

AUA 2026: Dehydrated Human Amniotic Membrane for Early Return of Erectile Function After Robotic Radical Prostatectomy: A 10-Year Journey and Lessons Learned

AUA 2026: State-of-the-Art Lecture: Contemporary Perioperative Non-Opioid Pain Management Strategies

APCCC 2026: Which Patients Planned for Salvage Radiotherapy Need Systemic Therapy and for How Long?

APCCC 2026: How to Select Patients with mHSPC for ADT plus an ARPI plus a Targeted Therapy (PARP or AKT Inhibition)?

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer.

Impact of frailty on perioperative and oncologic outcomes after robotic radical prostatectomy: a multicenter study with competing risk analysis.

Defining the combinatorial nature of gene modules in prostate cancer underlying lineage plasticity and metastasis.

Early-access Use of Radioligand Therapy in Prostate Cancer.

Adverse pathology and low tumor volume in biopsy Gleason 3 + 4 prostate cancer: Toward safe expansion of active surveillance and focal therapy.

Therapy Optimization in mHSPC: Insights from a Multidisciplinary Uro-Oncology Expert Panel.

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Unveiling the Clinical Potential of Prostate Cancer Three-dimensional Models: A Systematic Review - Beyond the Abstract

Identification of Biomarkers Predictive of Successful Salvage Surgery in Prostate-specific Membrane Antigen Positron Emission Tomography-positive Oligorecurrent Prostate Cancer: Results from the BioPoP Trial - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC